The clinicopathologic significance of FOXC1 in BRCA-mutant breast cancer.

被引：0
|
作者：
Choi, Michael Phillip
Cui, Xiaojiang
Dadmanesh, Farnaz
Liles, Georgia
Zhang, Xiao
Karlan, Beth
Glullano, Armando E.
Amersi, Farin F.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Santa Monica, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1556
引用
收藏
页数：1
相关论文
共 50 条
  • [31] BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers
    D Tkocz
    N T Crawford
    N E Buckley
    F B Berry
    R D Kennedy
    J J Gorski
    D P Harkin
    P B Mullan
    Oncogene, 2012, 31 : 3667 - 3678
  • [32] Clinicopathologic Features of BRCA-Mutant NSCLC Patients Characterized by Comprehensive Histologic Subtyping and Comprehensive Genomic Profiling
    Suh, James
    Johnson, Adrienne
    Gay, Laurie
    Frampton, Garrett M.
    Garland, Linda
    Ali, Siraj
    Miller, Vincent A.
    Stephens, Philip M.
    Ross, Jeffrey S.
    Elvin, Julia A.
    MODERN PATHOLOGY, 2018, 31 : 751 - 751
  • [33] FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
    Jin, Yanli
    Han, Bingchen
    Chen, Jiongyu
    Wiedemeyer, Ruprecht
    Orsulic, Sandra
    Bose, Shikha
    Zhang, Xiao
    Karlan, Beth Y.
    Giuliano, Armando E.
    Cui, Yukun
    Cui, Xiaojiang
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S758 - S766
  • [34] Tangential migration defects in a mouse mutant for foxc1 recovered in a genetic screen
    Zarbalis, K.
    Choe, Y.
    Siegenthaler, J. A.
    Hecht, J.
    Pleasure, S. J.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2008, 26 (08) : 853 - 854
  • [35] FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
    Yanli Jin
    Bingchen Han
    Jiongyu Chen
    Ruprecht Wiedemeyer
    Sandra Orsulic
    Shikha Bose
    Xiao Zhang
    Beth Y. Karlan
    Armando E. Giuliano
    Yukun Cui
    Xiaojiang Cui
    Annals of Surgical Oncology, 2014, 21 : 758 - 766
  • [36] FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer
    Wang, Jinhua
    Xu, Yali
    Li, Li
    Wang, Lin
    Yao, Ru
    Sun, Qiang
    Du, Guanhua
    CANCER MEDICINE, 2017, 6 (01): : 275 - 287
  • [37] Conserved role of FOXC1 in TNBC is parallel to FOXA1 in ER+ breast cancer
    Ramachandran, Revathy
    Ibragimova, Shakhzada
    Woods, Laura M.
    AlHouqani, Tamader
    Gomez, Roshna Lawrence
    Simeoni, Fabrizio
    Hachim, Mahmood Y.
    Somervaille, Tim C. P.
    Philpott, Anna
    Carroll, Jason S.
    Ali, Fahad R.
    ISCIENCE, 2024, 27 (08)
  • [38] Evaluation of BRCA1 in human breast cancer.
    Liu, J
    Yin, Z
    Liu, W
    Yee, H
    Wieczoreck, R
    Inghirami, G
    Feiner, H
    LABORATORY INVESTIGATION, 1997, 76 (01) : 109 - 109
  • [39] FOXC1 promotes pancreatic cancer cell proliferation and metastasis
    Subramani, Ramadevi
    Camacho, Fernando A.
    Levin, Carly
    Medel, Joshua
    Kolli, Sai Navana
    Nandy, Sushmita Bose
    Pedroza, Diego A.
    Lakshmanaswamy, Rajkumar
    CANCER RESEARCH, 2017, 77
  • [40] Drug-induced evolutionary dynamics in BRCA-mutant/non-mutant ovarian cancer models
    Garces, A. H. Ingles Russo
    Milite, S.
    Oliveira, E.
    Fernandez-Mateos, J.
    Chen, B.
    Pickard, L.
    Stewart, A.
    Lau, R.
    Brandon, A. De Haven
    Paranjape, E.
    Sottoriva, A.
    Banerjee, S.
    Banerji, U.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1316 - S1316
12345